1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Obsessive Compulsive Disorder: new trials by email Literature Review of Obsessive Compulsive Disorder trials Research Report on Obsessive Compulsive Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder Troriluzole (BHV-4157) - Obsessive Compulsive Disorder | Phase 3 | Terminated | Biohaven Pharmaceuticals, Inc. | 772 | 2021-03-30 | 2026-02-25 |
Obsessive-Compulsive Disorder (1)
Anxiety Disorders (1) · Mental Disorders (1)
Biohaven Pharmaceuticals, Inc. (1)
Canada (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)